Selecta Biosciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Selecta Biosciences generated cash of -$51,161,000, which is less than the previous year. Cash used in financing activities reached the amount of -$13,145,000 last year. Net change in cash is therefore -$29,750,000.
Cash Flow
| 2014 | -12.68M | -227K | 24.77M |
|---|---|---|---|
| 2015 | -22.46M | -4.67M | 43.90M |
| 2016 | -19.68M | -22.1M | 67.65M |
| 2017 | -52.03M | -2.09M | 66.02M |
| 2018 | -59.16M | 25.27M | 697K |
| 2019 | -51.43M | 229K | 105.04M |
| 2020 | 34.88M | -741K | 14.43M |
| 2021 | -60.38M | -17.14M | 52.89M |
| 2022 | -31.63M | -15.00M | 39.21M |
| 2023 | -51.16M | 34.60M | -13.14M |
SELB Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 108.03M | 115.43M | 140.06M | 91.55M | 37.68M | 71.02M | 58.65M | 32.33M | 16.59M | 8.05M |
Operating activities | ||||||||||
Net income | -219.71M | 35.37M | -25.68M | -68.87M | -55.35M | -65.33M | -65.32M | -36.21M | -25.17M | -12.88M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 764K | 1.28M | 1.25M | 734K | 2.02M | 975K | 750K | 802K | 1.04M | 864K |
Stock-based compensation expense | 0 | 11.19M | 7.72M | 5.42M | 5.16M | 5.71M | 4.08M | 2.05M | 1.12M | 1.22M |
| Deferred income tax benefit | 0 | 11.19M | 7.72M | 5.42M | 5.16M | 5.71M | 4.08M | 2.05M | 1.12M | 1.22M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 726K | 3.31M | -2.69M | -2.22M | -5M | 0 | 152K | 610K | -153K | -514K |
Inventories | 0 | 0 | 211K | -7.17M | 782K | 0 | 6.17M | -605K | -557K | 316K |
Accounts payable | 2.83M | 92K | -219K | -57K | -600K | -516K | -2.32M | 2.68M | 667K | -90K |
Cash generated by operating activities | -51.16M | -31.63M | -60.38M | 34.88M | -51.43M | -59.16M | -52.03M | -19.68M | -22.46M | -12.68M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -33.50M | -32.45M | 0 | -18.18M | -15.59M | -61.52M | -28.41M | -3.51M | 0 |
Investments In Property Plant And Equipment | -206K | -1.20M | -1.08M | -815K | -47K | -884K | -733K | -586K | -1.16M | -227K |
Acquisitions Net | 0 | 13.80M | 2M | 0 | 0 | 0 | -60.15M | -6.89M | 0 | 0 |
Cash generated by investing activities | 34.60M | -15.00M | -17.14M | -741K | 229K | 25.27M | -2.09M | -22.1M | -4.67M | -227K |
Financing activities | ||||||||||
Common Stock Issued | 20.25M | 0 | 0 | 12.37M | 107.66M | 0 | 57.11M | 71.61M | 109K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 231K | 0 | 0 | 184K | 28K | 0 | 180K | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -19.31M | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | -13.14M | 39.21M | 52.89M | 14.43M | 105.04M | 697K | 66.02M | 67.65M | 43.90M | 24.77M |
Net Change In Cash | -29.75M | -7.39M | -24.62M | 48.51M | 53.86M | -33.34M | 11.96M | 26.31M | 15.74M | 8.53M |
Cash at end of period | 78.28M | 108.03M | 115.43M | 140.06M | 91.55M | 37.68M | 70.62M | 58.65M | 32.33M | 16.59M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |